Eribulin mesylate in the treatment of metastatic breast cancer
Sarika Jain, Tessa CiglerDepartment of Medicine, Weill Cornell Medical College, New York, NY, USAAbstract: The treatment of metastatic breast cancer (MBC) has become increasingly challenging as the primary goals of therapy include prolonging life without added toxicity. While multiple agents are app...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-01-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/eribulin-mesylate-in-the-treatment-of-metastatic-breast-cancer-a9034 |